Virpax Pharmaceuticals

NasdaqCM:VRPX Stock Report

Mkt Cap: US$13.5m

Virpax Pharmaceuticals Management

How experienced are the management team and are they aligned to shareholders interests?

5.1yrs

Average management tenure


CEO

Tony Mack (60 yo)

5.33yrs

Tenure

US$758,000

Compensation

Mr. Anthony P. Mack, also known as Tony, M.B.A, serves as Chairman and Chief Executive Officer of Virpax Pharmaceuticals, Inc. since May 2017 and has been its Director since May 2017. Mr. Mack is a Founder...


CEO Compensation Analysis

Compensation vs Market: Tony's total compensation ($USD758.00K) is about average for companies of similar size in the US market ($USD776.35K).

Compensation vs Earnings: Tony's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: VRPX's management team is seasoned and experienced (5.1 years average tenure).


Board Members

Experienced Board: VRPX's board of directors are considered experienced (5.3 years average tenure).